Nipah patient given second dose of monoclonal antibody drug
A 43-year-old Nipah virus patient in Kerala has received a second dose of a monoclonal antibody drug and remains in critical condition. Health authorities report no new cases, with a limited number of individuals currently under observation.
Why it matters
Monitoring the treatment of rare, high-mortality viruses like Nipah is critical for public health preparedness and containment strategies.
Health Minister K. Muraleedharan has said that the 43-year-old Nipah patient undergoing treatment at the Government Medical College Hospital here has been given the second dose of the monoclonal antibody drug.
The report is a straightforward factual update on a public health situation.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in